BioAdaptives, Inc.
BDPT
$0.0006
$0.000120.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 20.44% | 56.31% | 12.39% | 11.84% | 14.71% |
| Total Depreciation and Amortization | -54.66% | -61.53% | -95.39% | -79.53% | -53.51% |
| Total Amortization of Deferred Charges | -50.04% | -39.11% | -2.54% | 38.62% | 10.23% |
| Total Other Non-Cash Items | 73.77% | -64.02% | 304.62% | 172.60% | -39.57% |
| Change in Net Operating Assets | -88.87% | -86.64% | -87.40% | -71.08% | -22.45% |
| Cash from Operations | 1.54% | 31.97% | 20.06% | -16.36% | -43.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -33.37% | 59.15% | -26.35% | -36.57% | -23.98% |
| Total Debt Repaid | -85.87% | -85.87% | 100.00% | 75.27% | -24.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.68% | 55.34% | -11.39% | -28.95% | -28.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.67% | 383.94% | 82.80% | -257.59% | -173.31% |
